Edition:
United States

Intellipharmaceutics International Inc (IPCI.OQ)

IPCI.OQ on NASDAQ Stock Exchange Capital Market

0.69USD
3:59pm EST
Change (% chg)

$-0.01 (-1.43%)
Prev Close
$0.70
Open
$0.71
Day's High
$0.71
Day's Low
$0.67
Volume
12,045
Avg. Vol
53,535
52-wk High
$2.91
52-wk Low
$0.66

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.05 November 22 Feb 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 2 3 2 2
(3) HOLD 1 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 1.75 1.67 1.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Feb-18 2 1.28 1.33 1.23 19.29
Quarter Ending May-18 2 1.34 1.39 1.29 19.77
Year Ending Nov-18 4 9.29 15.80 6.17 44.97
Year Ending Nov-19 3 19.79 26.30 11.52 75.19
Earnings (per share)
Quarter Ending Feb-18 2 -0.05 -0.05 -0.05 0.38
Quarter Ending May-18 2 -0.05 -0.05 -0.06 0.39
Year Ending Nov-18 4 -0.18 -0.01 -0.28 0.67
Year Ending Nov-19 3 -0.08 0.05 -0.20 1.65

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Nov-17 1.30 1.08 0.22 16.81
Quarter Ending Aug-17 2.64 1.19 1.46 55.02
Quarter Ending May-17 1.84 2.00 0.16 8.91
Quarter Ending Feb-17 1.84 1.24 0.60 32.70
Quarter Ending Nov-16 1.32 0.57 0.75 56.79

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Feb-18 1.28 1.28 4.95 8.67 19.29
Quarter Ending May-18 1.34 1.34 5.41 9.52 19.77
Year Ending Nov-18 9.29 9.29 15.96 19.22 44.97
Year Ending Nov-19 19.79 19.79 29.97 29.97 75.19

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Feb-18 0 0 0 1
Quarter Ending May-18 0 0 0 1
Year Ending Nov-18 0 0 0 1
Year Ending Nov-19 0 0 0 1
Earnings